Publications by authors named "Kenneth Flanagan"

Claim this Profile
D
Development of a humanized anti-fibrin monoclonal antibody for the treatment of neuroinflammatory and retinal diseases.
Aaron B Kantor, Mathias Rickert, Hank Cheng, Kenneth Flanagan, Vasudha Salgotra

J Neuroinflammation· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic Targeting of CD146/MCAM Reduces Bone Metastasis in Prostate Cancer.
Eugenio Zoni, Letizia Astrologo, Charlotte K Y Ng, Salvatore Piscuoglio, Janine Melsen, Kenneth Flanagan

Mol Cancer Res· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemokines in tumor immunotherapy.
Kenneth Flanagan, Howard L Kaufman

Front Biosci· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The lymphoid chemokine CCL21 costimulates naive T cell expansion and Th1 polarization of non-regulatory CD4+ T cells.
Kenneth Flanagan, Dorota Moroziewicz, Heesun Kwak, Heidi Hörig, Howard L Kaufman

Cell Immunol· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Local delivery of recombinant vaccinia virus expressing secondary lymphoid chemokine (SLC) results in a CD4 T-cell dependent antitumor response.
Kenneth Flanagan, Robert T Glover, Heidi Hörig, Wancai Yang, Howard L Kaufman

Vaccine· July 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemokines and cancer.
Kenneth Flanagan, Howard L Kaufman

Cancer Invest· September 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis